![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Seminoma - 65 Studies Found
Recruiting |
: Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle : Testicular Germ Cell Tumor : 2007-12-25 :
|
Completed |
: ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors : Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) : 2010-01-21 : Drug: Tivantinib (ARQ 197) Capsule, 120 mg, BID (360 mg), approximately 112 days |
Recruiting |
: Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer :
: 2015-01-14 :
|
Recruiting |
: Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma :
: 2000-01-28 :
|
Completed |
: Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients :
|
Completed |
: Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer : Testicular Germ Cell Tumor : 1999-11-01 :
|
Terminated |
: Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer :
|
Recruiting |
: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors :
|
Completed |
: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors :
|
Completed |
: Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer :
|